China-Japan Union Hospital of Jilin University
Changchun 130033
4 studies enrolling now · 6 studies all time
What they study most
Atherosclerotic Cardiovascular Disease, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Dyslipidemias, Familial Hypercholesterolemia, Heart Failure, High Cholesterol, Hypercholesterolemia, Hypertension, Lipoprotein Disorder, Ulcerative Colitis
Studies at this site
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Recruiting now
- A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure — Recruiting now
- A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart — Recruiting now
- Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a) — Recruiting now
- A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
- Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies — Completed